GMABGenmab A/S
$37.06+31% 1Y
$37.06
$23.8552 weeks$38.47
Is the price fair?
What GMAB's price assumes
Genmab A/S has no trailing P/E on file, so the price is measured against sales instead: 0.04× revenue.
0.04
Price / sales · no trailing P/E on file: measured against sales instead
- Price / book
- 0.04
Price / book · as of 2024-H2
Details›
- Price / bookas of 2024-H2
- 0.04
- Market capitalisation
- $16.0B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.